HSBC Analysts Give Siemens Healthineers (ETR:SHL) a €42.00 Price Target

HSBC set a €42.00 ($48.84) price target on Siemens Healthineers (ETR:SHL) in a research report released on Monday, Borsen Zeitung reports. The firm currently has a neutral rating on the stock.

Other equities research analysts have also recently issued reports about the stock. UBS Group set a €37.00 ($43.02) price objective on shares of Siemens Healthineers and gave the stock a neutral rating in a research report on Monday, November 4th. Nord/LB set a €36.00 ($41.86) price target on shares of Siemens Healthineers and gave the stock a neutral rating in a report on Monday, July 29th. Royal Bank of Canada set a €36.00 ($41.86) price target on shares of Siemens Healthineers and gave the stock a neutral rating in a report on Monday, November 4th. Barclays set a €38.00 ($44.19) price target on shares of Siemens Healthineers and gave the stock a neutral rating in a report on Thursday, November 7th. Finally, Independent Research set a €43.00 ($50.00) price target on shares of Siemens Healthineers and gave the stock a neutral rating in a report on Wednesday, November 6th. One analyst has rated the stock with a sell rating, twelve have given a hold rating and four have issued a buy rating to the stock. Siemens Healthineers presently has an average rating of Hold and an average price target of €39.49 ($45.92).

Shares of SHL traded down €0.09 ($0.10) during trading hours on Monday, hitting €43.41 ($50.47). 330,904 shares of the stock were exchanged. Siemens Healthineers has a fifty-two week low of €33.05 ($38.42) and a fifty-two week high of €43.80 ($50.92). The company has a debt-to-equity ratio of 42.65, a current ratio of 1.39 and a quick ratio of 0.96. The business has a 50-day moving average of €38.43 and a 200-day moving average of €36.87. The firm has a market capitalization of $43.41 billion and a P/E ratio of 27.65.

Siemens Healthineers Company Profile

Siemens Healthineers AG develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services to healthcare providers worldwide. It operates in three operating segments: Imaging, Advanced Therapies, and Diagnostics. The Imaging segment provides diagnostic imaging and ultrasound systems and solutions.

See Also: What are the benefits of investing in REITs?

Analyst Recommendations for Siemens Healthineers (ETR:SHL)

Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.